Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differential Cognitive Effects of DHA-Enriched and Standard Phosphatidylserine Formulations in Children With ADHD: A Randomized Placebo-Controlled Trial

NCT07521449 is registered in ClinicalTrials.gov with Çağlar Charles Daniel Jaicks as lead sponsor.

NCT NCT07521449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07521449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differential Cognitive Effects of DHA-Enriched and Standard Phosphatidylserine Formulations in Children With ADHD: A Randomized Placebo-Controlled Trial
Lead sponsor
Çağlar Charles Daniel Jaicks
Phase
Not applicable
Overall status
Completed
Start date
December 30, 2023
Completion date
June 1, 2025
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, attention deficit hyperactivity disorder (adhd)